Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards


Up to now, quality assurance (QA) and quality control (QC) in metabolomics are procedures that most labs did using their own in-house developed procedures and rules since there was no consensus or minimum requirement. Now there is a lot of enthusiasm for developing standardization of QA and QC procedures.

This is a preview of subscription content, log in to check access.


  1. Bearden, D. W., Beger, R. D., Broadhurst, D., Dunn, W., Edison, A., Guillou, C., et al. (2014). The New Data Quality Task Group (DQTG): Ensuring high quality data today and in the future. Metabolomics, 10(4), 539.

    CAS  Article  Google Scholar 

  2. Beger, R. D., Dunn, W. B., Bandukwala, A., Bethan, B., Broadhurst, D., Clish, C., et al. (2018). Think tank on quality assurance and quality control in untargeted metabolomics studies. Metabolomics.

    Article  Google Scholar 

  3. Beger, R. D., Dunn, W., Schmidt, M. A., Gross, S. S., Kirwan, J. A., Cascante, M., et al. (2016). Metabolomics enables precision medicine: “A white paper, community perspective. Metabolomics, 12, 149.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Broadhurst, D., Goodacre, R., Reinke, S. N., Kuligowski, J., Wilson, I. D., Lewis, M. R., et al. (2018). Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics, 14, 72.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. Clayton, T. A., Baker, D., Lindon, J. C., Everrett, J. R., & Nicholson, J. K. (2009). Pharmacometabolomics identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proceedings of the National Academy of Sciences of the United States of America, 106(34), 14728–14733.

    CAS  Article  Google Scholar 

  6. Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIn- tyre, S., Anderson, N., et al. (2011). Procedures for large-scale metabolic profile of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols, 6(7), 1060–1083.

    CAS  Article  Google Scholar 

  7. Dunn, W. B., Broadhurst, D. I., Edison, A., Guillou, C., Viant, M. R., Bearden, D. W., et al. (2017). Quality assurance and quality control processes: Summary of a metabolomics community questionnaire. Metabolomics, 13(5), 50.

    Article  Google Scholar 

  8. Fiehn, O., Robertson, D., Griffin, J., van der Werf, M., Nikolau, B., Morrison, N., et al. (2007). The metabolomics standards initiative (MSI). Metabolomics, 3, 175–178.

    CAS  Article  Google Scholar 

  9. Kaddurah-Daouk, R., Weinshilboum, R. M., & Pharmacometabolomics Research Network. (2014). Pharma-cometabolomics: Implications for clinical pharmacology and systems pharmacology. Clinical Pharmacology and Therapeutics, 95(2), 154–167.

    CAS  Article  Google Scholar 

  10. Lewis, M. R., Pearce, J. T., Spagou, K., Green, M., Dona, A. C., Yuen, A. H., et al. (2016). Development and application of ultra-performance liquid chromatorgraphy-TOF MS for precision large scale urinary metabolic phenotyping. Analytical Chemistry, 88(18), 9004–9013.

    CAS  Article  Google Scholar 

  11. Sangster, T., Major, H., Plumb, R., Wilson, A. J., & Wilson, I. D. (2006). A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst, 131(10), 1075–1078.

    CAS  Article  Google Scholar 

  12. Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., et al. (2006). The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nature Biotechnology, 24(9), 1151–1161.

    CAS  Article  Google Scholar 

  13. Shi, L., Perkins, R. G., Fang, H., & Tong, W. (2008). Reproducible and reliable microarray results through quality control: Good laboratory proficiency and appropriate data analysis practices are essential. Current Opinion in Biotechnology, 19(1), 10–18.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Richard D. Beger.

Ethics declarations

Conflict of interest

The author declares that does not have any conflicts of interest.

Research involving human and animal participants

This manuscript does not contain any studies with human participants or animals that performed by the author.

Additional information


The findings and conclusions in this article have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Beger, R.D. Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards. Metabolomics 15, 1 (2019).

Download citation


  • Quality control
  • Metabolomics
  • Biomarkers
  • Harmonizing QC standards